Theleme Partners LLP
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 13, 2026), Theleme Partners LLP reported 9 stock positions worth $1.7 billion. Its top holding was Moderna (MRNA) at 33.5% of the portfolio, followed by Meta Platforms Class A (META, 15.4%) and Uber Technologies (UBER, 13.7%). Compared with Q1 2026, it opened 2 new positions, sold out of 2 and added to 6. The biggest buy was a new position in Equinix (EQIX) and the biggest sale an exit from Flutter Entertainment PLC-Di (FLUT).
- Most Recent 13F
- Q2 2026
- Location
- London, X0
- CIK
- 0001511881
- Portfolio Value
- $1.7B (Q2 2026)
- SEC Filing
- 0000919574-26-005121 ↗ filed Aug 13, 2026
Holdings Value
Holdings 9 stocks · $1.7B
| MRNA Moderna Inc. | 33.52% | 8,057,571 | $564.3M | Add +0.1% |
| META Meta Platforms Inc. Class A | 15.37% | 459,450 | $258.8M | Add +1.9% |
| UBER Uber Technologies Inc. | 13.70% | 3,196,550 | $230.7M | Add +0.4% |
| AMZN Amazon.com Inc. | 11.65% | 822,979 | $196.1M | Add +11.8% |
| TRU Transunion | 10.15% | 2,369,757 | $171.0M | Add +2.3% |
| EQIX Equinix Inc. | 6.54% | 105,603 | $110.1M | New |
| EFX Equifax Inc. | 5.41% | 574,213 | $91.1M | Add +6.1% |
| HDB HDFC Bank Ltd.-ADR | 2.39% | 1,554,554 | $40.2M | New |
| SIFY Sify Technologies-Spon ADR | 1.26% | 1,278,683 | $21.2M | No change |
Portfolio Sells Q1 2026 → Q2 2026
Portfolio Buys Q1 2026 → Q2 2026
| EQIX Equinix Inc. | New | 6.54% | +6.54 |
| MRNA Moderna Inc. | Add +0.1% | 33.52% | +6.28 |
| HDB HDFC Bank Ltd.-ADR | New | 2.39% | +2.39 |
| AMZN Amazon.com Inc. | Add +11.8% | 11.65% | +1.44 |
| TRU Transunion | Add +2.3% | 10.15% | −0.52 |
| EFX Equifax Inc. | Add +6.1% | 5.41% | −1.08 |
| UBER Uber Technologies Inc. | Add +0.4% | 13.70% | −1.55 |
| META Meta Platforms Inc. Class A | Add +1.9% | 15.37% | −1.82 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $1.7B | MRNA, META, UBER, AMZN, TRU |
| Q1 2026 | 9 | $1.5B | MRNA, META, UBER, TRU, AMZN |
| Q4 2025 | 9 | $1.5B | META, MRNA, FLUT, TRU, WFC |
| Q3 2025 | 10 | $1.6B | META, WFC, MRNA, TRU, UBER |
| Q2 2025 | 10 | $1.6B | MRNA, WFC, META, TRU, FLUT |
| Q1 2025 | 12 | $1.3B | MRNA, AMZN, WFC, TRU, EFX |
| Q4 2024 | 11 | $1.5B | MRNA, BAC, WFC, AMZN, EFX |
| Q3 2024 | 10 | $1.7B | MRNA, SCHW, TRU, EFX, HRI |
| Q2 2024 | 8 | $2.0B | MRNA, SCHW, WFC, TRU, HRI |
| Q1 2024 | 7 | $1.8B | MRNA, SCHW, WFC, HRI, TRU |